HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm

TheSchall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstHims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (NYSE: HIMS)forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who […]

LINE Investors Have Opportunity to Join Lineage, Inc. Fraud Investigation With the DJS Law Group

The DJS Law Group reminds investors that it is investigating claims against Lineage, Inc. (“Lineage” or “the Company”) (NASDAQ: LINE) for violations of securities laws. Shareholders who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents issued in connection with its initial public offering (“IPO”) conducted in July 2024, should contact the

Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results

Multiple Ongoing Phase 2b Studies Advancing HBV Functional Cure Strategy Greater China Partnership with Joincare to Accelerate Development of Critical Care Antibiotic soralimixin Strong Cash Position to Pursue New Discovery Opportunities and Partnership Strategy Conference Calls Scheduled:English Session: August 21 at 9:00 p.m. HKT / 9:00 a.m. ETChinese Session: August 22 at 9:00 a.m. HKT

Bilibili Inc. Announces Second Quarter 2025 Financial Results

(NASDAQ:BILI),(HKSE:9626), SHANGHAI, Aug. 21, 2025 (GLOBE NEWSWIRE) — Bilibili Inc. (“Bilibili” or the “Company”) (Nasdaq: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights: Total net revenues were RMB7.34

Bilibili Inc. Announces Second Quarter 2025 Financial Results

Bilibili Inc. Announces Second Quarter 2025 Financial Results GlobeNewswire August 21, 2025 SHANGHAI, Aug. 21, 2025 (GLOBE NEWSWIRE) — Bilibili Inc. (“Bilibili” or the “Company”) (Nasdaq: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced its unaudited financial results for the second quarter ended June

Wishpond Advances IP Portfolio with Patent Filing for Self-Testing Technology

— Wishpond files patent application for its new self-testing technology that strengthens its virtual AI agents with rigorous pre-engagement simulations, bringing more human-like accuracy and reliability to customer interactions. — This is the fourth patent application Wishpond has filed, reinforcing its leadership in AI-driven marketing technology. The Self-Testing technology is already being used with Wishpond's

Vitria Revolutionizes Financial Services IT with Autonomous AI Operations

Vitria, a leader in AI operations, is transforming how financial services firms manage their complex IT environments. With the escalating scale and intricacy of modern financial systems, manual operations are becoming increasingly unsustainable, leading to significant financial losses and reputational damage from disruptions. https://mma.prnewswire.com/media/2489838/Vitria_Logov1.jpg Vitria's innovativeVIA AIOps platformis shifting the industry from reactive “eyes on

Pasteur Labs acquires AI startup FOSAI, to accelerate adoption of AI-driven physics simulation for space & defense applications

Strategic acquisition combines Pasteur's next-generation physics simulation platform with proven autonomous systems integration expertise for critical systems and dual-use markets. Pasteur Labs, the pioneering developer of Simulation Intelligence (SI) technologies and applications that natively integrate AI/ML and physics simulation, today announced its acquisition ofFOSAI, a specialized provider of space systems & autonomy solutions for the

IgniteData Appoints Dr. David Rhew, Global Chief Medical Officer of Microsoft, to Board of Directors

IgniteData, a leader in intelligent clinical trial data automation, is proud to announce the appointment of Dr. David Rhew, Global Chief Medical Officer and Vice President of Healthcare at Microsoft, to its Board of Directors. https://mma.prnewswire.com/media/2533102/IgniteData_Full_Color_Logo.jpg Dr. Rhew brings decades of experience at the intersection of healthcare, technology, innovation, and clinical research. He pioneered the

West to Participate in Upcoming Investor Conferences in September 2025

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at multiple investor conferences in September. Here are the details of the presentations: https://mma.prnewswire.com/media/890850/west_pharma_large_Logo.jpg — Wells Fargo 2025 Healthcare Conference: Fireside chat at 3:00 PM ET on Wednesday, September 3, 2025 in Boston,

Scroll to Top